Inventor · disambiguated record
Tara Maddala
Also filed as: MADDALA TARA
10 granted patents·15 pending applications·20 citations·filing 2009–2025
84Inventor score
Top patents by PatentIndex Score
25 records- 0186US12412642B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2023·Granted Sep 9, 2025·0 cites·20 claims
- 0286US10260104B2Method for using gene expression to determine prognosis of prostate cancerGENOMIC HEALTH INC·Filed 2015·Granted Apr 16, 2019·2 cites·11 claims
- 0386US9551034B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerCOWENS WAYNE·Filed 2011·Granted Jan 24, 2017·5 cites·12 claims
- 0485US2025129432A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerMDXHEALTH SA·Filed 2024·Application pending·0 cites
- 0582US8725426B2Gene expression profile algorithm and test for determining prognosis of prostate cancerGENOMIC HEALTH INC·Filed 2013·Granted May 13, 2014·12 cites·22 claims
- 0678US2022396842A1Method for using gene expression to determine prognosis of prostate cancerMDXHEALTH SA·Filed 2022·Application pending·0 cites
- 0775US10181008B2Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancerGENOMIC HEALTH INC·Filed 2014·Granted Jan 15, 2019·1 cites·17 claims
- 0874US11776664B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2020·Granted Oct 3, 2023·0 cites·20 claims
- 0972US2019249260A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2019·Application pending·0 cites
- 1069US2025349431A1Multi-Assay Prediction Model for Cancer DetectionGRAIL INC·Filed 2025·Application pending·0 cites
- 1169US2020255911A1Method for Using Gene Expression to Determine Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2020·Application pending·0 cites
- 1268US2025218568A1Early detection tools for mental healthPANDORA BIO INC·Filed 2024·Application pending·0 cites
- 1367US8273534B2Predictors of patient response to treatment with EGF receptor inhibitorsBAKER JOFFRE B·Filed 2009·Granted Sep 25, 2012·0 cites·12 claims
- 1466US11551782B2Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancerGENOMIC HEALTH INC·Filed 2020·Granted Jan 10, 2023·0 cites·19 claims
- 1565US2025305058A1Algorithms and Methods for Assessing Late Clinical Endpoints in Prostate CancerMDX HEALTH SA·Filed 2025·Application pending·0 cites
- 1664US10892038B2Method to use gene expression to determine likelihood of clinical outcome of renal cancerGENOMIC HEALTH INC·Filed 2016·Granted Jan 12, 2021·0 cites·22 claims
- 1764US2014303002A1Gene Expression Profile Algorithm and Test for Determining Prognosis of Prostate CancerGENOMIC HEALTH INC·Filed 2014·Application pending·0 cites
- 1861US2025327130A1Use of cell-free dna fragmentomes in the diagnostic evaluation of patients with signs and symptoms suggestive of cancerDELFI DIAGNOSTICS INC·Filed 2023·Application pending·0 cites
- 1958US11011252B1Gene expression profile algorithm and test for determining prognosis of prostate cancerGENOMIC HEALTH INC·Filed 2017·Granted May 18, 2021·0 cites·13 claims
- 2058US2019095575A1Gene Expression Profile Algorithm for Calculating a Recurrence Score for a Patient with Kidney CancerGENOMIC HEALTH INC·Filed 2018·Application pending·0 cites
- 2157US2012028264A1Method for using gene expression to determine prognosis of prostate cancerSHAK STEVEN·Filed 2011·Application pending·0 cites
- 2256US2010151463A1Method for Determining the Likelihood of Response to HER2 InhibitorsBAEHNER FREDERICK L·Filed 2009·Application pending·0 cites
- 2356US2012270228A1Predictors of patient response to treatment with egf receptor inhibitorsBAKER JOFFRE B·Filed 2012·Application pending·0 cites
- 2454US2020040400A1Algorithms and Methods for Assessing Late Clinical Endpoints in Prostate CancerGENOMIC HEALTH INC·Filed 2018·Application pending·0 cites
- 2546US2019316209A1Multi-Assay Prediction Model for Cancer DetectionGRAIL INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →